Viking Global Investors Lp

13F Holdings History for Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI)

Symbol: TRVI on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share
Latest Disclosed Ownership: 5.13M shares
Security Ownership: 4.2%

Shares, Excluding Options vs Price

Value, Excluding Options

VIKING GLOBAL INVESTORS LP ownership in Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI)

2025-11-14 - VIKING GLOBAL INVESTORS LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.13M shares of Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI). This represents 4.2% percent ownership of the company. In their previous filing dated 2025-08-14, VIKING GLOBAL INVESTORS LP had reported owning 7.51M shares, indicating a decrease of -31.7% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
VIKING GLOBAL INVESTORS LP	4.2%	-28.3%	$46.9M	5.13M	-2,376,819	-31.7%	$9.15	13G/A	9/30/2025	14 Nov 2025 16:55:28
VIKING GLOBAL INVESTORS LP	5.9%	-31.1%	$56.2M	7.51M	-1,684,792	-18.3%	$7.49	13G/A	6/30/2025	14 Aug 2025 17:35:10
VIKING GLOBAL INVESTORS LP	8.7%		$55.6M	9.19M			$6.05	13G/A	3/31/2025	15 May 2025 16:34:45

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.12%	+0.09%	$46.9M	5.13M	+3,585,875	+232%	$9.15	Q3 2025
6/30/2025	0.02%	-0.03%	$8.44M	1.54M	-1,684,792	-52.2%	$5.47	Q2 2025
3/31/2025	0.06%	-0.02%	$20.3M	3.23M	-1,172,208		$6.29	Q1 2025
12/31/2024	0.06%		$18.1M	4.4M			$4.12	Q4 2024
9/30/2024	0.05%		$14.7M	4.4M			$3.34	Q3 2024
6/30/2024	0.05%		$13.1M	4.4M			$2.98	Q2 2024
3/31/2024	0.06%		$15.2M	4.4M			$3.45	Q1 2024
12/31/2023	0.02%		$5.9M	4.4M			$1.34	Q4 2023
9/30/2023	0.04%		$9.59M	4.4M			$2.18	Q3 2023
6/30/2023	0.04%		$10.5M	4.4M			$2.39	Q2 2023
3/31/2023	0.04%		$8.14M	4.4M			$1.85	Q1 2023
12/31/2022	0.04%		$8.49M	4.4M			$1.93	Q4 2022
9/30/2022	0.03%	+0.03%	$6.78M	4.4M	+4,400,000	NEW	$1.54	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.